Synergistic effect of chloroquine and panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair

[EN]Ovarian cancer (OC) is the deadliest gynecologic malignancy, which is mainly due to late-stage diagnosis and chemotherapy resistance. Therefore, new and more effective treatments are urgently needed. The in vitro effects of Panobinostat (LBH), a histone deacetylase inhibitor that exerts pleiotro...

Descripción completa

Detalles Bibliográficos
Autores: Ovejero-Sánchez, María, González Sarmiento, Rogelio, Herrero Hernández, Ana Belén
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/164471
Acceso en línea:http://hdl.handle.net/10366/164471
Access Level:acceso abierto
Palabra clave:Antineoplastic agents
Cell line
Cancer
DNA damage
DNA repair
Drug synergism
Cloroquine
Panobinostat
Chloroquine
Reactive Oxygen Species
Drug Synergism
Humans
DNA Damage
Cell Line
Antineoplastic Agents
Autophagy
DNA Repair
Cell Cycle Checkpoints
Cell Survival
Apoptosis
Ovarian Neoplasms
DNA Breaks
Recombinational DNA Repair
apoptosis
daño del ADN
humanos
línea celular
autofagia
reparación del ADN por recombinación
cloroquina
neoplasias ováricas
antineoplásicos
roturas del ADN
puntos de comprobación del ciclo celular
reparación del ADN
especies reactivas de oxígeno
sinergismo farmacológico
supervivencia celular
Descripción
Sumario:[EN]Ovarian cancer (OC) is the deadliest gynecologic malignancy, which is mainly due to late-stage diagnosis and chemotherapy resistance. Therefore, new and more effective treatments are urgently needed. The in vitro effects of Panobinostat (LBH), a histone deacetylase inhibitor that exerts pleiotropic antitumor effects but induces autophagy, in combination with Chloroquine (CQ), an autophagy inhibitor that avoid this cell survival mechanism, were evaluated in 4 OC cell lines. LBH and CQ inhibited ovarian cancer cell proliferation and induced apoptosis, and a strong synergistic effect was observed when combined. Deeping into their mechanisms of action we show that, in addition to autophagy modulation, treatment with CQ increased reactive oxygen species (ROS) causing DNA double strand breaks (DSBs), whereas LBH inhibited their repair by avoiding the correct recruitment of the recombinase Rad51 to DSBs. Interestingly, CQ-induced DSBs and cell death caused by CQ/LBH combination were largely abolished by the ROS scavenger N-Acetylcysteine, revealing the critical role of DSB generation in CQ/LBH-induced lethality. This role was also manifested by the synergy found when we combined CQ with Mirin, a well-known homologous recombination repair inhibitor. Altogether, our results provide a rationale for the clinical investigation of CQ/LBH combination in ovarian cancer.